Similar articles

• A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.

  Winston DJ, Antin JH, Wolff SN, Bierer BE, Small T, Miller KB, Linker C, Kaizer H, Lazarus HM, Petersen FB, Cowan MJ, Ho WG, Wingard JR, Schiller GJ, Territo MC, Jiao J, Petrarca MA, Tonetta SA. Winston DJ, et al. Bone Marrow Transplant. 2001 Jul;28(2):187-96. doi: 10.1038/sj.bmt.1703109. Bone Marrow Transplant. 2001. PMID: 11509937 Clinical Trial.
• Bone marrow transplantation at the University of Minnesota.

  McGlave PB, Ramsay NK, Kersey JH. McGlave PB, et al. Minn Med. 1982 Jun;65(6):351-4. Minn Med. 1982. PMID: 7050650 No abstract available.
• Serum neopterin in patients receiving bone marrow transplant.

  Pavletić Z, Labar B, Bogdanić V, Nemet D, Mrsić M, Stavljenić A, Cvoriscec D, Presecki V, Petrovecki M. Pavletić Z, et al. Bone Marrow Transplant. 1989 Dec;4 Suppl 3:97-8. Bone Marrow Transplant. 1989. PMID: 2627615 No abstract available.
• [Aplastic anemia].

  Dorantes S, de la Soledad Córdova M, Pizzuto J, Gónzalez Llaven J. Dorantes S, et al. Gac Med Mex. 1989 Nov-Dec;125(11-12):341-60. Gac Med Mex. 1989. PMID: 2699298 Review. Spanish. No abstract available.
• Allogeneic bone marrow transplantation in the treatment of hematologic diseases.

  Yee GC, McGuire TR. Yee GC, et al. Clin Pharm. 1985 Mar-Apr;4(2):149-60. Clin Pharm. 1985. PMID: 3886273 Review.